Stock LLY ELI LILLY AND COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Company Eli Lilly and Company

Equities

LLY

US5324571083

Pharmaceuticals

Market Closed - Nyse
Other stock markets
 04:00:05 2024-05-16 pm EDT 		5-day change 1st Jan Change
771.6 USD -1.96% Intraday chart for Eli Lilly and Company +0.00% +32.36%
May. 16 Health Care Flat as Momentum Wanes -- Health Care Roundup DJ
May. 16 Eli Lilly: research collaboration with Totus Medicines CF

Business Summary

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:

- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;

- oncology (19.5%);

- immunology diseases (11.1%);

- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;

- other (3.3%).

Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).

Number of employees: 43,000

Sales per Business

USD in Million2022Weight2023Weight Delta
Human Pharmaceutical Products
100.0 %
28,541 100.0 % 34,124 100.0 % +19.56%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
63.9 %
18,190 63.7 % 21,791 63.9 % +19.80%
Europe
18.1 %
4,299 15.1 % 6,175 18.1 % +43.62%
Other Foreign Countries
8.6 %
2,852 10.0 % 2,946 8.6 % +3.30%
Japan
4.9 %
1,747 6.1 % 1,673 4.9 % -4.28%
China
4.5 %
1,453 5.1 % 1,540 4.5 % +5.98%

Managers

Managers TitleAgeSince
David Ricks CEO
 Chief Executive Officer 56 95-12-31
Anat Ashkenazi DFI
 Director of Finance/CFO 51 00-12-31
Ruth Gimeno PSD
 President - -
Diogo Rau CTO
 Chief Tech/Sci/R&D Officer - 21-05-16
David Hyman CTO
 Chief Tech/Sci/R&D Officer - 23-10-15
Alonzo Weems CMP
 Compliance Officer - 96-12-31
Daniel Skovronsky CTO
 Chief Tech/Sci/R&D Officer 50 17-12-31
Edgardo Hernandez PRN
 Corporate Officer/Principal - 04-12-31
Ilya Yuffa PRN
 Corporate Officer/Principal 49 -
Ronald DeMattos PRN
 Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Gabrielle Greene-Sulzberger BRD
 Director/Board Member 63 21-01-24
Ralph Alvarez BRD
 Director/Board Member 68 09-03-31
Jon Fyrwald BRD
 Director/Board Member 63 04-12-31
Juan Luciano BRD
 Director/Board Member 62 16-01-31
William Kaelin BRD
 Director/Board Member 66 12-06-03
David Ricks CEO
 Chief Executive Officer 56 95-12-31
Jamere Jackson BRD
 Director/Board Member 54 16-09-30
Katherine Baicker BRD
 Director/Board Member 52 11-12-11
Marschall Runge BRD
 Director/Board Member 69 13-08-31
Karen Walker BRD
 Director/Board Member 62 18-11-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 950,770,386 948,828,863 ( 99.80 %) 365,000 ( 0.0384 %) 99.80 %

Shareholders

NameEquities%Valuation
Lilly Endowment, Inc.
10.40 %
98,898,810 10.40 % 77 250 M $
Vanguard Fiduciary Trust Co.
7.651 %
72,745,011 7.651 % 56 821 M $
The Vanguard Group, Inc.
7.531 %
71,604,696 7.531 % 55 930 M $
PNC Investments LLC
5.410 %
51,438,196 5.410 % 40 178 M $
BlackRock Advisors LLC
5.286 %
50,259,761 5.286 % 39 258 M $
STATE STREET CORPORATION
3.603 %
34,258,566 3.603 % 26 759 M $
Fidelity Management & Research Co. LLC
3.583 %
34,063,734 3.583 % 26 607 M $
Capital Research & Management Co. (World Investors)
2.581 %
24,536,055 2.581 % 19 165 M $
PRIMECAP Management Co.
2.235 %
21,254,190 2.235 % 16 602 M $
T. Rowe Price International Ltd.
2.168 %
20,613,061 2.168 % 16 101 M $
NameEquities%Valuation
Caixa DTVM SA
0.001476 %
421,310 0.001476 % 11 M $
Western Asset Management Company DTVM Ltda.
0.000707 %
201,841 0.000707 % 5 M $
Bram Bradesco Asset Management S/A DTVM
0.000172 %
49,010 0.000172 % 1 M $
Safra Asset Management Ltda.
0.000157 %
44,900 0.000157 % 1 M $
Warren Brasil Gestão e Administração e Recursos Ltda.
0.000041 %
11,739 0.000041 % 306 866 $
XP Allocation Asset Management Ltda.
0.000014 %
3,883 0.000014 % 101 504 $
BTG Pactual WM Gestão de Recursos Ltda.
0.000009 %
2,450 0.000009 % 64 045 $

Holdings

NameEquities%Valuation
DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.
6.83%
 8,084,411 6.83% 50,293,848 $
PROQR THERAPEUTICS N.V.
16.55%
 13,371,562 16.55% 26,208,262 $
FOGHORN THERAPEUTICS INC.
9.40%
 4,000,000 9.40% 20,920,000 $
MICROTECH MEDICAL (HANGZHOU) CO., LTD.
7.60%
 21,776,804 7.60% 11,332,213 $
AC IMMUNE SA
3.64%
 3,615,328 3.64% 8,279,101 $
PRECISION BIOSCIENCES, INC.
1.81%
 125,405 1.81% 1,218,937 $

Company contact information

Eli Lilly & Co.

Lilly Corporate Center

46285, Indianapolis

+317 276 2000

http://www.lilly.com
address Eli Lilly and Company(LLY)

Group companies

NameCategory and Sector
ELI Lilly & Company (India) Pvt Ltd.
Logo ELI Lilly & Company (India) Pvt Ltd.

ELI Lilly & Company (India) Pvt Ltd.

Pharmaceuticals: MajorHealth Technology

ELI Lilly & Company (India) Pvt Ltd. manufactures and markets pharmaceutical products. The firm's products treat diabetes, gastric cancer, lung cancer, osteoporosis, rheumatoid arthritis, men's health and growth-hormone deficiency. The company was founded in 1993 and is headquartered in Gurgaon, India.

Pharmaceuticals: Major
Eli Lilly Services India Pvt Ltd.
Logo Eli Lilly Services India Pvt Ltd.

Eli Lilly Services India Pvt Ltd.

Pharmaceuticals: MajorHealth Technology

Part of Eli Lilly & Co., Eli Lilly Services India Pvt Ltd. is an Indian company that discovers, develops, manufactures and sells pharmaceutical products. The company is based in Bangalore, India and was founded in 2015.

Pharmaceuticals: Major
Eli Lilly Export SA (Switzerland)
Logo Eli Lilly Export SA (Switzerland)

Eli Lilly Export SA (Switzerland)

Medical DistributorsDistribution Services

Part of Eli Lilly & Co., Eli Lilly Export SA is a pharmaceutical company based in Vernier, Switzerland. The Swiss company combines care with research to develop innovative solutions for a better life worldwide.

Medical Distributors
Kinsale Financial Services
Lilly Nederland Finance BV
Logo Lilly Nederland Finance BV

Lilly Nederland Finance BV

Miscellaneous Commercial ServicesCommercial Services

Part of Eli Lilly & Co., Lilly Nederland Finance BV leases non-financial intangible assets. The company is based in Utrecht, Netherlands.

Miscellaneous Commercial Services
Eli Lilly SA
Logo Eli Lilly SA

Eli Lilly SA

Pharmaceuticals: MajorHealth Technology

Part of Eli Lilly & Co., Eli Lilly SA is a Swiss company that manufactures medicines. The company is based in Vernier, Switzerland.

Pharmaceuticals: Major
Eli Lilly (Suisse) SA
Lilly Global Nederland Holdings BV
Logo Lilly Global Nederland Holdings BV

Lilly Global Nederland Holdings BV

Financial ConglomeratesFinance

Part of Eli Lilly & Co., Lilly Global Nederland Holdings BV functions as an investment holding Dutch company. The company is based in Utrecht, Netherlands.

Financial Conglomerates
Eli Lilly Vostok SA

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
771.1 USD
Average target price
850.4 USD
Spread / Average Target
+10.28%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.36% 694B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+31.17% 593B
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.60% 371B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.07% 331B
ABBVIE INC. Stock AbbVie Inc.
+6.04% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.64% 239B
NOVARTIS AG Stock Novartis AG
+9.98% 209B
ROCHE HOLDING AG Stock Roche Holding AG
-3.27% 209B
AMGEN INC. Stock Amgen Inc.
+9.27% 169B
PFIZER, INC. Stock Pfizer, Inc.
+0.45% 164B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. LLY Stock
  4. Company Eli Lilly and Company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW